APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biopharmaceuticals

A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Selected research

Industry Growth & Trends

Global Biopharmaceuticals Industry Growth and Trends Forecast to 2032

1 January 2026120 pages

Choose your research edition.

Industry ResearchBiopharmaceuticals Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Biopharmaceuticals Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Biopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biopharmaceuticals Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Biopharmaceuticals Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

According to APO Research, the global Biopharmaceuticals market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

Read the full market overview

The Europe market for Biopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

The Asia Pacific market for Biopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Biopharmaceuticals market include Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biopharmaceuticals market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biopharmaceuticals market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biopharmaceuticals market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biopharmaceuticals.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Biopharmaceuticals market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biopharmaceuticals Market by Company

Roche

Amgen

AbbVie

Sanofi-Aventis

Johnson & Johnson

Pfizer

Novo Nordisk

Eli Lilly

Novartis

Merck

Sun

3sbio

Changchun High Tech

CP Guojian

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

United Laboratories

SANDOZ (NOVARTIS)

Teva Pharmaceutical

Hospira （Pfizer）

MYLAN

Sun pharma

Biopharmaceuticals Segment by Type

Monoclonal Antibodies

Interferon

Colony-Stimulating Factor

Erythropoietin

Insulin

Vaccines

Growth Hormones

Others

Biopharmaceuticals Segment by Application

Tumor

Diabetes

Cardiovascular

Hemophilia

Others

Biopharmaceuticals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Biopharmaceuticals companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Biopharmaceuticals Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Biopharmaceuticals Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Biopharmaceuticals Market Share by Region (2021-2026) Table 4. Global Biopharmaceuticals Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Biopharmaceuticals Market Share by Region (2027-2032) Table 6. Global Biopharmaceuticals Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Biopharmaceuticals Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Biopharmaceuticals Market Size Share by Type (2021-2026) Table 9. Global Biopharmaceuticals Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Biopharmaceuticals Market Size Share Forecasted by Type (2027-2032) Table 11. North America Biopharmaceuticals Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Biopharmaceuticals Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Biopharmaceuticals Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Biopharmaceuticals Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Biopharmaceuticals Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Biopharmaceuticals Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Biopharmaceuticals Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Biopharmaceuticals Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Biopharmaceuticals Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Biopharmaceuticals Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Biopharmaceuticals Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Biopharmaceuticals Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Biopharmaceuticals Market Size Share by Application (2021-2026) Table 24. Global Biopharmaceuticals Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Biopharmaceuticals Market Size Share Forecasted by Application (2027-2032) Table 26. North America Biopharmaceuticals Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Biopharmaceuticals Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Biopharmaceuticals Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Biopharmaceuticals Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Biopharmaceuticals Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Biopharmaceuticals Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Biopharmaceuticals Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Biopharmaceuticals Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Biopharmaceuticals Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Biopharmaceuticals Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Biopharmaceuticals Industry Trends Table 37. Biopharmaceuticals Industry Drivers Table 38. Biopharmaceuticals Industry Opportunities and Challenges Table 39. Biopharmaceuticals Industry Restraints Table 40. Global Biopharmaceuticals Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Biopharmaceuticals Revenue Market Share by Company (2021-2026) Table 42. Global Biopharmaceuticals Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Biopharmaceuticals Key Company Headquarters & Area Served Table 44. Global Biopharmaceuticals Company, Product Type & Application Table 45. Global Biopharmaceuticals Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Biopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Roche Company Information Table 49. Roche Business Overview Table 50. Roche Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Roche Biopharmaceuticals Product Portfolio Table 52. Roche Recent Development Table 53. Amgen Company Information Table 54. Amgen Business Overview Table 55. Amgen Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Amgen Biopharmaceuticals Product Portfolio Table 57. Amgen Recent Development Table 58. AbbVie Company Information Table 59. AbbVie Business Overview Table 60. AbbVie Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. AbbVie Biopharmaceuticals Product Portfolio Table 62. AbbVie Recent Development Table 63. Sanofi-Aventis Company Information Table 64. Sanofi-Aventis Business Overview Table 65. Sanofi-Aventis Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Sanofi-Aventis Biopharmaceuticals Product Portfolio Table 67. Sanofi-Aventis Recent Development Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Johnson & Johnson Biopharmaceuticals Product Portfolio Table 72. Johnson & Johnson Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Pfizer Biopharmaceuticals Product Portfolio Table 77. Pfizer Recent Development Table 78. Novo Nordisk Company Information Table 79. Novo Nordisk Business Overview Table 80. Novo Nordisk Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Novo Nordisk Biopharmaceuticals Product Portfolio Table 82. Novo Nordisk Recent Development Table 83. Eli Lilly Company Information Table 84. Eli Lilly Business Overview Table 85. Eli Lilly Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Eli Lilly Biopharmaceuticals Product Portfolio Table 87. Eli Lilly Recent Development Table 88. Novartis Company Information Table 89. Novartis Business Overview Table 90. Novartis Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Novartis Biopharmaceuticals Product Portfolio Table 92. Novartis Recent Development Table 93. Merck Company Information Table 94. Merck Business Overview Table 95. Merck Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Merck Biopharmaceuticals Product Portfolio Table 97. Merck Recent Development Table 98. Sun Company Information Table 99. Sun Business Overview Table 100. Sun Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Sun Biopharmaceuticals Product Portfolio Table 102. Sun Recent Development Table 103. 3sbio Company Information Table 104. 3sbio Business Overview Table 105. 3sbio Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. 3sbio Biopharmaceuticals Product Portfolio Table 107. 3sbio Recent Development Table 108. Changchun High Tech Company Information Table 109. Changchun High Tech Business Overview Table 110. Changchun High Tech Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Changchun High Tech Biopharmaceuticals Product Portfolio Table 112. Changchun High Tech Recent Development Table 113. CP Guojian Company Information Table 114. CP Guojian Business Overview Table 115. CP Guojian Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. CP Guojian Biopharmaceuticals Product Portfolio Table 117. CP Guojian Recent Development Table 118. Biotech Company Information Table 119. Biotech Business Overview Table 120. Biotech Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Biotech Biopharmaceuticals Product Portfolio Table 122. Biotech Recent Development Table 123. Gelgen Company Information Table 124. Gelgen Business Overview Table 125. Gelgen Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Gelgen Biopharmaceuticals Product Portfolio Table 127. Gelgen Recent Development Table 128. Innovent Company Information Table 129. Innovent Business Overview Table 130. Innovent Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Innovent Biopharmaceuticals Product Portfolio Table 132. Innovent Recent Development Table 133. Dong Bao Company Information Table 134. Dong Bao Business Overview Table 135. Dong Bao Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Dong Bao Biopharmaceuticals Product Portfolio Table 137. Dong Bao Recent Development Table 138. Ganlee Company Information Table 139. Ganlee Business Overview Table 140. Ganlee Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Ganlee Biopharmaceuticals Product Portfolio Table 142. Ganlee Recent Development Table 143. United Laboratories Company Information Table 144. United Laboratories Business Overview Table 145. United Laboratories Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. United Laboratories Biopharmaceuticals Product Portfolio Table 147. United Laboratories Recent Development Table 148. SANDOZ (NOVARTIS) Company Information Table 149. SANDOZ (NOVARTIS) Business Overview Table 150. SANDOZ (NOVARTIS) Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. SANDOZ (NOVARTIS) Biopharmaceuticals Product Portfolio Table 152. SANDOZ (NOVARTIS) Recent Development Table 153. Teva Pharmaceutical Company Information Table 154. Teva Pharmaceutical Business Overview Table 155. Teva Pharmaceutical Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Teva Pharmaceutical Biopharmaceuticals Product Portfolio Table 157. Teva Pharmaceutical Recent Development Table 158. Hospira （Pfizer） Company Information Table 159. Hospira （Pfizer） Business Overview Table 160. Hospira （Pfizer） Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Hospira （Pfizer） Biopharmaceuticals Product Portfolio Table 162. Hospira （Pfizer） Recent Development Table 163. MYLAN Company Information Table 164. MYLAN Business Overview Table 165. MYLAN Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. MYLAN Biopharmaceuticals Product Portfolio Table 167. MYLAN Recent Development Table 168. Sun pharma Company Information Table 169. Sun pharma Business Overview Table 170. Sun pharma Biopharmaceuticals Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. Sun pharma Biopharmaceuticals Product Portfolio Table 172. Sun pharma Recent Development Table 173. North America Biopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. North America Biopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 175. North America Biopharmaceuticals Market Share by Country (2021-2026) Table 176. North America Biopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. North America Biopharmaceuticals Market Share Forecast by Country (2027-2032) Table 178. Europe Biopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Europe Biopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 180. Europe Biopharmaceuticals Market Share by Country (2021-2026) Table 181. Europe Biopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Europe Biopharmaceuticals Market Share Forecast by Country (2027-2032) Table 183. Asia-Pacific Biopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Asia-Pacific Biopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 185. Asia-Pacific Biopharmaceuticals Market Share by Country (2021-2026) Table 186. Asia-Pacific Biopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Asia-Pacific Biopharmaceuticals Market Share Forecast by Country (2027-2032) Table 188. Latin America Biopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Latin America Biopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 190. Latin America Biopharmaceuticals Market Share by Country (2021-2026) Table 191. Latin America Biopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Latin America Biopharmaceuticals Market Share Forecast by Country (2027-2032) Table 193. Middle East & Africa Biopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Middle East & Africa Biopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 195. Middle East & Africa Biopharmaceuticals Market Share by Country (2021-2026) Table 196. Middle East & Africa Biopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Middle East & Africa Biopharmaceuticals Market Share Forecast by Country (2027-2032) Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Biopharmaceuticals Product Image Figure 3. Global Biopharmaceuticals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 5. Global Biopharmaceuticals Market Share by Region: 2025 VS 2032 Figure 6. Global Biopharmaceuticals Market Share by Region (2021-2032) Figure 7. North America Biopharmaceuticals Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Biopharmaceuticals Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Biopharmaceuticals Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Biopharmaceuticals Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Biopharmaceuticals Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Monoclonal Antibodies Image Figure 13. Global Monoclonal Antibodies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Interferon Image Figure 15. Global Interferon Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Colony-Stimulating Factor Image Figure 17. Global Colony-Stimulating Factor Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Erythropoietin Image Figure 19. Global Erythropoietin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Insulin Image Figure 21. Global Insulin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Vaccines Image Figure 23. Global Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Growth Hormones Image Figure 25. Global Growth Hormones Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Others Image Figure 27. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Global Biopharmaceuticals Market Size Overview by Type (2021-2032) & (US$ Million) Figure 29. Global Biopharmaceuticals Market Share by Type 2025 VS 2032 Figure 30. North America Biopharmaceuticals Market Size Share by Type (2021-2032) Figure 31. Europe Biopharmaceuticals Market Size Share by Type (2021-2032) Figure 32. Asia-Pacific Biopharmaceuticals Market Size Share by Type (2021-2032) Figure 33. Latin America Biopharmaceuticals Market Size Share by Type (2021-2032) Figure 34. Middle East and Africa Biopharmaceuticals Market Size Share by Type (2021-2032) Figure 35. Tumor Image Figure 36. Global Tumor Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Diabetes Image Figure 38. Global Diabetes Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Cardiovascular Image Figure 40. Global Cardiovascular Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Hemophilia Image Figure 42. Global Hemophilia Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. Others Image Figure 44. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Global Biopharmaceuticals Market Size Overview by Application (2021-2032) & (US$ Million) Figure 46. Global Biopharmaceuticals Market Share by Application 2025 VS 2032 Figure 47. North America Biopharmaceuticals Market Size Share by Application (2021-2032) Figure 48. Europe Biopharmaceuticals Market Size Share by Application (2021-2032) Figure 49. Asia-Pacific Biopharmaceuticals Market Size Share by Application (2021-2032) Figure 50. Latin America Biopharmaceuticals Market Size Share by Application (2021-2032) Figure 51. Middle East and Africa Biopharmaceuticals Market Size Share by Application (2021-2032) Figure 52. Global Top 5 and 10 Biopharmaceuticals Players Market Share by Revenue in 2025 Figure 53. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 54. North America Biopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. North America Biopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. North America Biopharmaceuticals Market Share by Country (2021-2032) Figure 57. Europe Biopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Biopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Biopharmaceuticals Market Share by Country (2021-2032) Figure 60. Asia-Pacific Biopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Asia-Pacific Biopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Biopharmaceuticals Market Share by Country (2021-2032) Figure 63. Latin America Biopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Biopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Biopharmaceuticals Market Share by Country (2021-2032) Figure 66. Middle East & Africa Biopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 67. Middle East & Africa Biopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 68. Middle East & Africa Biopharmaceuticals Market Share by Country (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibodies
  • Interferon
  • Colony-Stimulating Factor
  • Erythropoietin
  • Insulin
  • Vaccines
  • Growth Hormones
  • Others
Applications
  • Tumor
  • Diabetes
  • Cardiovascular
  • Hemophilia
  • Others
Companies covered
  • Roche
  • Amgen
  • AbbVie
  • Sanofi-Aventis
  • Johnson & Johnson
  • Pfizer
  • Novo Nordisk
  • Eli Lilly
  • Novartis
  • Merck
  • Sun
  • 3sbio
  • Changchun High Tech
  • CP Guojian
  • Biotech
  • Gelgen
  • Innovent
  • Dong Bao
  • Ganlee
  • United Laboratories
  • SANDOZ (NOVARTIS)
  • Teva Pharmaceutical
  • Hospira （Pfizer）
  • MYLAN
  • Sun pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Biopharmaceuticals Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Biopharmaceuticals Market Size by Region (2021-2032)
  5. 1.4.1 Global Biopharmaceuticals Market Size by Region (2021-2026)
  6. 1.4.2 Global Biopharmaceuticals Market Size by Region (2027-2032)
  7. 1.5 Key Regions Biopharmaceuticals Market Size (2021-2032)
  8. 1.5.1 North America Biopharmaceuticals Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Biopharmaceuticals Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Biopharmaceuticals Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Biopharmaceuticals Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Biopharmaceuticals Market Size Growth Rate (2021-2032)
2 Biopharmaceuticals Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Monoclonal Antibodies
  3. 2.1.2 Interferon
  4. 2.1.3 Colony-Stimulating Factor
  5. 2.1.4 Erythropoietin
  6. 2.1.5 Insulin
  7. 2.1.6 Vaccines
  8. 2.1.7 Growth Hormones
  9. 2.1.8 Others
  10. 2.2 Global Biopharmaceuticals Market Size by Type
  11. 2.2.1 Global Biopharmaceuticals Market Size Overview by Type (2021-2032)
  12. 2.2.2 Global Biopharmaceuticals Historic Market Size Review by Type (2021-2026)
  13. 2.2.3 Global Biopharmaceuticals Market Size Forecasted by Type (2027-2032)
  14. 2.3 Global Biopharmaceuticals Market Size by Regions
  15. 2.3.1 North America Biopharmaceuticals Market Size Breakdown by Type (2021-2026)
  16. 2.3.2 Europe Biopharmaceuticals Market Size Breakdown by Type (2021-2026)
  17. 2.3.3 Asia-Pacific Biopharmaceuticals Market Size Breakdown by Type (2021-2026)
  18. 2.3.4 South America Biopharmaceuticals Market Size Breakdown by Type (2021-2026)
  19. 2.3.5 Middle East and Africa Biopharmaceuticals Market Size Breakdown by Type (2021-2026)
3 Biopharmaceuticals Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Tumor
  3. 3.1.2 Diabetes
  4. 3.1.3 Cardiovascular
  5. 3.1.4 Hemophilia
  6. 3.1.5 Others
  7. 3.2 Global Biopharmaceuticals Market Size by Application
  8. 3.2.1 Global Biopharmaceuticals Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Biopharmaceuticals Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Biopharmaceuticals Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Biopharmaceuticals Market Size by Regions
  12. 3.3.1 North America Biopharmaceuticals Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Biopharmaceuticals Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Biopharmaceuticals Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Biopharmaceuticals Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Biopharmaceuticals Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Biopharmaceuticals Industry Trends
  2. 4.2 Biopharmaceuticals Industry Drivers
  3. 4.3 Biopharmaceuticals Industry Opportunities and Challenges
  4. 4.4 Biopharmaceuticals Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Biopharmaceuticals Revenue (2021-2026)
  2. 5.2 Global Biopharmaceuticals Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Biopharmaceuticals Key Company Headquarters & Area Served
  4. 5.4 Global Biopharmaceuticals Company, Product Type & Application
  5. 5.5 Global Biopharmaceuticals Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Biopharmaceuticals Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Biopharmaceuticals Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Biopharmaceuticals Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Roche Biopharmaceuticals Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Amgen
  8. 6.2.1 Amgen Company Information
  9. 6.2.2 Amgen Business Overview
  10. 6.2.3 Amgen Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Amgen Biopharmaceuticals Product Portfolio
  12. 6.2.5 Amgen Recent Developments
  13. 6.3 AbbVie
  14. 6.3.1 AbbVie Company Information
  15. 6.3.2 AbbVie Business Overview
  16. 6.3.3 AbbVie Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 AbbVie Biopharmaceuticals Product Portfolio
  18. 6.3.5 AbbVie Recent Developments
  19. 6.4 Sanofi-Aventis
  20. 6.4.1 Sanofi-Aventis Company Information
  21. 6.4.2 Sanofi-Aventis Business Overview
  22. 6.4.3 Sanofi-Aventis Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi-Aventis Biopharmaceuticals Product Portfolio
  24. 6.4.5 Sanofi-Aventis Recent Developments
  25. 6.5 Johnson & Johnson
  26. 6.5.1 Johnson & Johnson Company Information
  27. 6.5.2 Johnson & Johnson Business Overview
  28. 6.5.3 Johnson & Johnson Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Johnson & Johnson Biopharmaceuticals Product Portfolio
  30. 6.5.5 Johnson & Johnson Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Biopharmaceuticals Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Novo Nordisk
  38. 6.7.1 Novo Nordisk Company Information
  39. 6.7.2 Novo Nordisk Business Overview
  40. 6.7.3 Novo Nordisk Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Novo Nordisk Biopharmaceuticals Product Portfolio
  42. 6.7.5 Novo Nordisk Recent Developments
  43. 6.8 Eli Lilly
  44. 6.8.1 Eli Lilly Company Information
  45. 6.8.2 Eli Lilly Business Overview
  46. 6.8.3 Eli Lilly Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Eli Lilly Biopharmaceuticals Product Portfolio
  48. 6.8.5 Eli Lilly Recent Developments
  49. 6.9 Novartis
  50. 6.9.1 Novartis Company Information
  51. 6.9.2 Novartis Business Overview
  52. 6.9.3 Novartis Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Novartis Biopharmaceuticals Product Portfolio
  54. 6.9.5 Novartis Recent Developments
  55. 6.10 Merck
  56. 6.10.1 Merck Company Information
  57. 6.10.2 Merck Business Overview
  58. 6.10.3 Merck Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Merck Biopharmaceuticals Product Portfolio
  60. 6.10.5 Merck Recent Developments
  61. 6.11 Sun
  62. 6.11.1 Sun Company Information
  63. 6.11.2 Sun Business Overview
  64. 6.11.3 Sun Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Sun Biopharmaceuticals Product Portfolio
  66. 6.11.5 Sun Recent Developments
  67. 6.12 3sbio
  68. 6.12.1 3sbio Company Information
  69. 6.12.2 3sbio Business Overview
  70. 6.12.3 3sbio Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 3sbio Biopharmaceuticals Product Portfolio
  72. 6.12.5 3sbio Recent Developments
  73. 6.13 Changchun High Tech
  74. 6.13.1 Changchun High Tech Company Information
  75. 6.13.2 Changchun High Tech Business Overview
  76. 6.13.3 Changchun High Tech Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Changchun High Tech Biopharmaceuticals Product Portfolio
  78. 6.13.5 Changchun High Tech Recent Developments
  79. 6.14 CP Guojian
  80. 6.14.1 CP Guojian Company Information
  81. 6.14.2 CP Guojian Business Overview
  82. 6.14.3 CP Guojian Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 CP Guojian Biopharmaceuticals Product Portfolio
  84. 6.14.5 CP Guojian Recent Developments
  85. 6.15 Biotech
  86. 6.15.1 Biotech Company Information
  87. 6.15.2 Biotech Business Overview
  88. 6.15.3 Biotech Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Biotech Biopharmaceuticals Product Portfolio
  90. 6.15.5 Biotech Recent Developments
  91. 6.16 Gelgen
  92. 6.16.1 Gelgen Company Information
  93. 6.16.2 Gelgen Business Overview
  94. 6.16.3 Gelgen Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Gelgen Biopharmaceuticals Product Portfolio
  96. 6.16.5 Gelgen Recent Developments
  97. 6.17 Innovent
  98. 6.17.1 Innovent Company Information
  99. 6.17.2 Innovent Business Overview
  100. 6.17.3 Innovent Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Innovent Biopharmaceuticals Product Portfolio
  102. 6.17.5 Innovent Recent Developments
  103. 6.18 Dong Bao
  104. 6.18.1 Dong Bao Company Information
  105. 6.18.2 Dong Bao Business Overview
  106. 6.18.3 Dong Bao Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Dong Bao Biopharmaceuticals Product Portfolio
  108. 6.18.5 Dong Bao Recent Developments
  109. 6.19 Ganlee
  110. 6.19.1 Ganlee Company Information
  111. 6.19.2 Ganlee Business Overview
  112. 6.19.3 Ganlee Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Ganlee Biopharmaceuticals Product Portfolio
  114. 6.19.5 Ganlee Recent Developments
  115. 6.20 United Laboratories
  116. 6.20.1 United Laboratories Company Information
  117. 6.20.2 United Laboratories Business Overview
  118. 6.20.3 United Laboratories Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 United Laboratories Biopharmaceuticals Product Portfolio
  120. 6.20.5 United Laboratories Recent Developments
  121. 6.21 SANDOZ (NOVARTIS)
  122. 6.21.1 SANDOZ (NOVARTIS) Company Information
  123. 6.21.2 SANDOZ (NOVARTIS) Business Overview
  124. 6.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 SANDOZ (NOVARTIS) Biopharmaceuticals Product Portfolio
  126. 6.21.5 SANDOZ (NOVARTIS) Recent Developments
  127. 6.22 Teva Pharmaceutical
  128. 6.22.1 Teva Pharmaceutical Company Information
  129. 6.22.2 Teva Pharmaceutical Business Overview
  130. 6.22.3 Teva Pharmaceutical Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Teva Pharmaceutical Biopharmaceuticals Product Portfolio
  132. 6.22.5 Teva Pharmaceutical Recent Developments
  133. 6.23 Hospira （Pfizer）
  134. 6.23.1 Hospira （Pfizer） Company Information
  135. 6.23.2 Hospira （Pfizer） Business Overview
  136. 6.23.3 Hospira （Pfizer） Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Hospira （Pfizer） Biopharmaceuticals Product Portfolio
  138. 6.23.5 Hospira （Pfizer） Recent Developments
  139. 6.24 MYLAN
  140. 6.24.1 MYLAN Company Information
  141. 6.24.2 MYLAN Business Overview
  142. 6.24.3 MYLAN Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 MYLAN Biopharmaceuticals Product Portfolio
  144. 6.24.5 MYLAN Recent Developments
  145. 6.25 Sun pharma
  146. 6.25.1 Sun pharma Company Information
  147. 6.25.2 Sun pharma Business Overview
  148. 6.25.3 Sun pharma Biopharmaceuticals Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 Sun pharma Biopharmaceuticals Product Portfolio
  150. 6.25.5 Sun pharma Recent Developments
7 North America
  1. 7.1 North America Biopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Biopharmaceuticals Market Size by Country (2021-2026)
  3. 7.3 North America Biopharmaceuticals Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Biopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Biopharmaceuticals Market Size by Country (2021-2026)
  3. 8.3 Europe Biopharmaceuticals Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Biopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Biopharmaceuticals Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Biopharmaceuticals Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Biopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Biopharmaceuticals Market Size by Country (2021-2026)
  3. 10.3 South America Biopharmaceuticals Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Biopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Biopharmaceuticals Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Biopharmaceuticals Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst